- Home
- ABVC vs JFU Comparison
ABVC vs JFU Comparison
Compare ABVC & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABVC | JFU |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.5M | 54.5M |
| IPO Year | 2009 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ABVC | JFU |
|---|---|---|
| Price | $1.47 | $4.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 48.5K | 3.2K |
| Earning Date | 06-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $509,589.00 | N/A |
| Revenue This Year | $735.18 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.43 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.61 | $1.01 |
| 52 Week High | $4.02 | $9.48 |
Technical Indicators
Market Signals| Indicator | ABVC | JFU |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 49.36 |
| Support Level | $1.15 | $4.24 |
| Resistance Level | $1.52 | $4.94 |
| Average True Range (ATR) | 0.12 | 0.30 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 56.63 | 41.26 |
Price Performance
Historical ComparisonAbout ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.